XENON PHARMACEUTICALS
Xenon Pharmaceuticals is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as Extreme Genetics. Our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits or phenotypes. They apply their expertise to predict which phenotypes are caused by single-gene defects. By identifying and characterizing the single-gene defects respo... nsible for such severe phenotypes, they gain valuable insights into their function in human biology and their potential as drug targets. Given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, they are developing proprietary product candidates to treat both orphans as well as more prevalent diseases
XENON PHARMACEUTICALS
Industry:
Biopharma Biotechnology Genetics Health Care Medical Pharmaceutical
Founded:
1996-01-01
Address:
Burnaby, British Columbia, Canada
Country:
Canada
Website Url:
http://www.xenon-pharma.com
Total Employee:
101+
Status:
Active
Contact:
(604) 484-3300
Email Addresses:
[email protected]
Total Funding:
942.59 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics WordPress Domain Not Resolving Wordpress Plugins Microsoft Exchange Online Office 365 Mail
Similar Organizations
HUTCHMED (China) Limited
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Antares Pharma
Antares Pharma is a specialty pharmaceutical company that focuses on commercializing therapeutic products.
Aprecia Pharmaceuticals
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Ascentage Pharma
Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.
Asieris Pharmaceuticals
Asieris Pharmaceuticals is a Chinese biotech company.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Collaborative Medicinal Development
Collaborative Medicinal Development is a privately-held biopharmaceutical company.
Constellation Pharmaceuticals
Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Kiora Pharmaceuticals
Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.
Gamma Medica
Gamma Medica offers LumaGEM® MBI System, an FDA-cleared dual-headed digital imaging system.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Hygea Medical Technology
Hygea Medical Technology is a oncology-focused biopharma company.
Iota Pharmaceuticals
Iota Pharmaceuticals is a new-style pharmaceutical discovery company
Mereo Biopharma
Mereo is a new UK-based speciality biopharmaceutical company.
Mitochon Pharmaceuticals
Mitochon Pharmaceuticals is a start-up biotech company.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
Oramed Pharmaceuticals
Oramed Pharmaceuticals develops proprietary Protein Oral Delivery technology for the delivery of drugs.
Organogenesis
Organogenesis Inc. is a regenerative medicine company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Universal Stabilization Technologies
Universal Stabilization Technologies is a San Diego-based biopharmaceutical R&D company.
VBL Therapeutics
VBL Therapeutics is a clinical-stage platform company developing targeted therapies for immune-inflammatory diseases.
Venatorx Pharmaceuticals
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Verrica Pharmaceuticals
Verrica Pharmaceuticals is an innovative clinical-stage medical dermatology company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Neurocrine Biosciences
Neurocrine Biosciences investment in Post-IPO Equity - Xenon Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Xenon Pharmaceuticals
Northview LifeSciences
Northview LifeSciences investment in Venture Round - Xenon Pharmaceuticals
Takeda
Takeda investment in Private Equity Round - Xenon Pharmaceuticals
Invesco Private Capital
Invesco Private Capital investment in Private Equity Round - Xenon Pharmaceuticals
JPMorgan Partners
JPMorgan Partners investment in Venture Round - Xenon Pharmaceuticals
Novo Ventures
Novo Ventures investment in Venture Round - Xenon Pharmaceuticals
InterWest Partners
InterWest Partners investment in Venture Round - Xenon Pharmaceuticals
RBC Venture Partners
RBC Venture Partners investment in Venture Round - Xenon Pharmaceuticals
GrowthWorks Capital
GrowthWorks Capital investment in Venture Round - Xenon Pharmaceuticals
Official Site Inspections
http://www.xenon-pharma.com Semrush global rank: 2.18 M Semrush visits lastest month: 9.05 K
- Host name: 52.188.162.20
- IP address: 52.188.162.20
- Location: Washington United States
- Latitude: 38.7095
- Longitude: -78.1539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 22747
More informations about "Xenon Pharmaceuticals"
Investor Overview | Xenon Pharmaceuticals Inc.
May 12, 2025 May 30, 2025 – Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 14, 2025 – Xenon to Present at the 2025 RBC Capital Markets … See details»
Xenon Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected]; Phone Number (604) 484-3300; Xenon Pharmaceuticals is a biopharmaceutical company focused on the … See details»
Xenon Pharmaceuticals Mission, Vision and Value Details
Contact US - Mr. C. M. Joshi (Prop.) (MD of the Company) Manufacturing Address : Plot No.: 598, M. K. Technology Park, Landran, Banur Highyway, SAS Nagar, Mohali ... See details»
Xenon Pharmaceuticals Inc. Management Team | Org Chart
Xenon-pharma.com; 3 781444XXXX; 978244XXXX; 978265XXXX; Matthew Ronsheim Chief Operating Officer at Xenon Pharmaceuticals Inc. Boston, MA, US View. 2 gmail.com; xenon … See details»
Xenon Pharmaceuticals, Inc. - Drug pipelines, Patents ... - Patsnap
May 7, 2025 All other trademarks belong to their respective owner. Contacts: For Investors: Chad Fugere Vice President, Investor Relations (857) 675-7275 [email protected] For … See details»
Xenon Pharmaceuticals - businessabc
Apr 16, 2025 Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada. History Xenon Pharmaceuticals Inc. is a publicly traded biopharmaceutical … See details»
XENON PHARMACEUTICALS INC. - investor.xenon-pharma.com
XENON PHARMACEUTICALS INC. (Exact Name of Registrant as Specified in its Charter) Canada. 98-0661854 (State or other jurisdiction of. incorporatio n or organization) (I .RSEmployer. Ide tifca … See details»
About | Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. 3650 Gilmore Way Burnaby, BC V5G 4W8. Tel: 604.484.3300 Fax: 604.484.3450 [email protected] See details»
Xenon Pharmaceuticals Inc. (XENE): history, …
Xenon Pharmaceuticals Inc. (XENE) Mission and Values Xenon Pharmaceuticals is dedicated to discovering, developing, and commercializing innovative therapeutics to improve the lives of patients with neurological … See details»
Xenon Pharmaceuticals (XENE) Company Profile & Description
Nov 5, 2014 Company profile for Xenon Pharmaceuticals Inc. (XENE) stock, with a description, list of executives, contact details and other key facts. See details»
Board of Directors - Xenon Pharmaceuticals Inc.
Mr. Machado has served as a member of our Board since November 2020. Mr. Machado co-founded and served as Chief Financial Officer and Chief Business Officer at Medivation, Inc. until his … See details»
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq …
6 days ago VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical … See details»
What is Xenon Pharmaceuticals? Company Culture, Mission, Values
How do job seekers rate their interview experience at Xenon Pharmaceuticals? 80% of job seekers rate their interview experience at Xenon Pharmaceuticals as positive. Candidates give an … See details»
Annual Financial Reports | Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. 3650 Gilmore Way Burnaby, BC V5G 4W8. Tel: 604.484.3300 Fax: 604.484.3450 See details»
Careers | Xenon Pharmaceuticals Inc.
At Xenon, we pride ourselves on having a positive and inclusive culture that is built upon our shared values. Xenon CARES about patients, employees, and those who put their trust in us. We are: C … See details»
Xenon Reports First Quarter 2025 Financial Results and Provides ...
May 12, 2025 For more information, please visit www.xenon-pharma.com. Safe Harbor Statement This press release contains forward-looking statements within the meaning of Section 27A of the … See details»
Advancing Neurology Therapies | Xenon Pharmaceuticals Inc.
Xenon to Report Q1 2025 Financial Results on May 12, 2025. Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Xenon to Showcase Long-Term 36 … See details»
XENON PHARMACEUTICALS INC. 2021 ANNUAL REPORT
XENON PHARMACEUTICALS INC. (Exact Name of Registrant as Specified in its Charter) Canada 98-0661854 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer … See details»
Product Pipeline - Xenon Pharma
Xenon Pharmaceuticals Inc. 3650 Gilmore Way Burnaby, BC V5G 4W8. Tel: 604.484.3300 Fax: 604.484.3450 [email protected] See details»
Xenon to Present at the Goldman Sachs 46th Annual Global
2 days ago [email protected]. For Media: Colleen Alabiso Senior Vice President, Corporate Affairs (617) 671-9238 [email protected]. Recommended Reading. See details»